Clinical Trial Update: Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

View source ↗

Summary

Observational study of patients with Type 2 diabetes treated with NovoRapid (insulin aspart) or soluble human insulin; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoRapid (insulin aspart)
• Soluble human insulin (human insulin (regular))

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED